PDB1 COST-EFFECTIVENESS OF SWITCHING PATIENTS TO COMBINED GLIBENCLAMIDE AND METFORMIN (GLUCOVANCE) WHEN POORLY CONTROLLED WITH METFORMIN MONOTHERAPY-THE FRENCH PERSPECTIVE
Nov 1, 2002, 00:00
10.1016/S1098-3015(10)61438-6
https://www.valueinhealthjournal.com/article/S1098-3015(10)61438-6/fulltext
Title :
PDB1 COST-EFFECTIVENESS OF SWITCHING PATIENTS TO COMBINED GLIBENCLAMIDE AND METFORMIN (GLUCOVANCE) WHEN POORLY CONTROLLED WITH METFORMIN MONOTHERAPY-THE FRENCH PERSPECTIVE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)61438-6&doi=10.1016/S1098-3015(10)61438-6
First page :
Section Title :
Open access? :
No
Section Order :
248